AAAAAA
Results: 1-25/32
Authors:
EISENHAUER EA
Citation: Ea. Eisenhauer, PHASE-II AND BEYOND - ASSESSMENT OF EFFICACY, Annals of oncology, 9, 1998, pp. 20-20
Authors:
EISENHAUER EA
Citation: Ea. Eisenhauer, PHASE-I AND PHASE-II TRIALS OF NOVEL ANTICANCER AGENTS - END-POINTS, EFFICACY AND EXISTENTIALISM, Annals of oncology, 9, 1998, pp. 29-29
Authors:
EISENHAUER EA
Citation: Ea. Eisenhauer, PHASE-I AND PHASE-II TRIALS OF NOVEL ANTICANCER AGENTS - END-POINTS, EFFICACY AND EXISTENTIALISM - THE MICHEL-CLAVEL-LECTURE, HELD AT THE 10TH NCI-EORTC CONFERENCE ON NEW DRUGS IN CANCER-THERAPY, AMSTERDAM, 16-19 JUNE 1998, Annals of oncology, 9(10), 1998, pp. 1047-1052
Authors:
SIU LL
OZA AM
EISENHAUER EA
FIRBY PS
THIESSEN JJ
MICHAEL M
WAINMAN N
MANZO J
FELD R
GOLDBERG RA
MOORE MJ
Citation: Ll. Siu et al., PHASE-I AND PHARMACOLOGICAL STUDY OF 9-AMINOCAMPTOTHECIN COLLOIDAL DISPERSION FORMULATION GIVEN AS A 24-HOUR CONTINUOUS-INFUSION WEEKLY TIMES 4 EVERY 5 WEEKS, Journal of clinical oncology, 16(3), 1998, pp. 1122-1130
Authors:
EISENHAUER EA
VERMORKEN JB
Citation: Ea. Eisenhauer et Jb. Vermorken, THE TAXOIDS - COMPARATIVE CLINICAL-PHARMACOLOGY AND THERAPEUTIC POTENTIAL, Drugs, 55(1), 1998, pp. 5-30
Authors:
EISENHAUER EA
VERMORKEN JB
VANGLABBEKE M
Citation: Ea. Eisenhauer et al., PREDICTORS OF RESPONSE TO SUBSEQUENT CHEMOTHERAPY IN PLATINUM PRETREATED OVARIAN-CANCER - A MULTIVARIATE-ANALYSIS OF 704 PATIENTS, Annals of oncology, 8(10), 1997, pp. 963-968
Authors:
DENT SF
EISENHAUER EA
Citation: Sf. Dent et Ea. Eisenhauer, PHASE-I TRIAL DESIGN - ARE NEW METHODOLOGIES BEING PUT INTO PRACTICE, Annals of oncology, 7(6), 1996, pp. 561-566
Authors:
TRUDEAU ME
EISENHAUER EA
HIGGINS BP
LETENDRE F
LOFTERS WS
NORRIS BD
VANDENBERG TA
DELORME F
MULDAL AM
Citation: Me. Trudeau et al., DOCETAXEL IN PATIENTS WITH METASTATIC BREAST-CANCER - A PHASE-II STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA - CLINICAL-TRIALS GROUP, Journal of clinical oncology, 14(2), 1996, pp. 422-428
Authors:
PERRAULT D
EISENHAUER EA
PRITCHARD KI
PANASCI L
NORRIS B
VANDENBERG T
FISHER B
Citation: D. Perrault et al., PHASE-II STUDY OF THE PROGESTERONE ANTAGONIST MIFEPRISTONE IN PATIENTS WITH UNTREATED METASTATIC BREAST-CARCINOMA - A NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY, Journal of clinical oncology, 14(10), 1996, pp. 2709-2712
Authors:
DANCEY J
EISENHAUER EA
Citation: J. Dancey et Ea. Eisenhauer, CURRENT PERSPECTIVES ON CAMPTOTHECINS IN CANCER-TREATMENT, British Journal of Cancer, 74(3), 1996, pp. 327-338
Authors:
PICCART MJ
RAYMOND E
AAPRO M
EISENHAUER EA
CVITKOVIC E
Citation: Mj. Piccart et al., CYTOTOXIC AGENTS WITH ACTIVITY IN BREAST-CANCER PATIENTS PREVIOUSLY EXPOSED TO ANTHRACYCLINES - CURRENT STATUS AND FUTURE-PROSPECTS, European journal of cancer, 31A, 1995, pp. 1-10
Authors:
EISENHAUER EA
VERMORKEN JB
MYLES J
VANGLABBEKE M
Citation: Ea. Eisenhauer et al., TUMOR BULK, HISTOLOGY, AND BASE-LINE HEMOGLOBIN MAY INFLUENCE RESPONSE (RR) IN PLATINUM PRETREATED OVARIAN-CANCER (OVCA), European journal of cancer, 31A, 1995, pp. 491-491
Authors:
BLACKSTEIN ME
EISENHAUER EA
BRAMWELL V
BELANGER K
VERMA S
BEARE S
Citation: Me. Blackstein et al., DOCETAXEL (TAXOTERE) AS FIRST-LINE THERAPY FOR METASTATIC OR RECURRENT SOFT-TISSUE SARCOMA (STS) - A PHASE-II TRIAL, European journal of cancer, 31A, 1995, pp. 848-848
Authors:
EISENHAUER EA
TRUDEAU M
Citation: Ea. Eisenhauer et M. Trudeau, AN OVERVIEW OF PHASE-II STUDIES OF DOCETAXEL IN PATIENTS WITH METASTATIC BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 11-13
Authors:
BRAMWELL VHC
EISENHAUER EA
BLACKSTEIN M
BOOS G
KNOWLING M
JOLIVET J
BOGUES W
Citation: Vhc. Bramwell et al., PHASE-II STUDY OF TOPOTECAN (NSC-609-699) IN PATIENTS WITH RECURRENT OR METASTATIC SOFT-TISSUE SARCOMA, Annals of oncology, 6(8), 1995, pp. 847-849
Authors:
BELCH AR
EISENHAUER EA
MULDAL A
BROWMAN G
KLASA R
OSTERWALDER B
Citation: Ar. Belch et al., PHASE-II STUDY OF SUBCUTANEOUS RHU-INTERLEUKIN-2 AND RHU-INTERFERON ALPHA-2A IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE-MYELOMA, Annals of oncology, 6(7), 1995, pp. 721-723
Authors:
CAIRNCROSS JG
EISENHAUER EA
Citation: Jg. Cairncross et Ea. Eisenhauer, RESPONSE AND CONTROL - LESSONS FROM OLIGODENDROGLIOMA, Journal of clinical oncology, 13(9), 1995, pp. 2475-2476
Authors:
EISENHAUER EA
Citation: Ea. Eisenhauer, DOCETAXEL - CURRENT STATUS AND FUTURE-PROSPECTS, Journal of clinical oncology, 13(12), 1995, pp. 2865-2868
Authors:
LATREILLE J
CORMIER Y
MARTINS H
GOSS G
FISHER B
EISENHAUER EA
Citation: J. Latreille et al., PHASE-II STUDY OF DOCETAXEL (TAXOTERE) IN PATIENTS WITH PREVIOUSLY UNTREATED EXTENSIVE SMALL-CELL LUNG-CANCER - A TRIAL OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP (NCIC CTG), Investigational new drugs, 13(4), 1995, pp. 343-345
Authors:
MERTENS WC
EISENHAUER EA
JOLIVET J
ERNST S
MOORE M
MULDAL A
Citation: Wc. Mertens et al., DOCETAXEL IN ADVANCED RENAL-CARCINOMA, Annals of oncology, 5(2), 1994, pp. 185-187
Authors:
EISENHAUER EA
LIPPMAN SM
KAVANAGH JJ
PARADESESPINOZA M
ARNOLD A
HONG WK
MASSIMINI G
SCHLEUNIGER U
BOLLAG W
HOLDENER EE
KRAKOFF I
Citation: Ea. Eisenhauer et al., COMBINATION 13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A IN THE THERAPY OF SOLID TUMORS, Leukemia, 8, 1994, pp. 38-41
Authors:
EISENHAUER EA
LIPPMAN SM
KAVANAGH JJ
PARADESESPINOZA M
ARNOLD A
HONG WK
MASSIMINI G
SCHLEUNIGER U
BOLLAG W
HOLDENER EE
KRAKOFF I
Citation: Ea. Eisenhauer et al., COMBINATION 13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A IN THE THERAPY OF SOLID TUMORS, Leukemia, 8(10), 1994, pp. 1622-1625
Authors:
EISENHAUER EA
HUININK WWT
SWENERTON KD
GIANNI L
MYLES J
VANDERBURG MEL
KERR I
VERMORKEN JB
BUSER K
COLOMBO N
BACON M
SANTABARBARA P
ONETTO N
WINOGRAD B
CANETTA R
Citation: Ea. Eisenhauer et al., EUROPEAN-CANADIAN RANDOMIZED TRIAL OF PACLITAXEL IN RELAPSED OVARIAN-CANCER - HIGH-DOSE VERSUS LOW-DOSE AND LONG VERSUS SHORT INFUSION, Journal of clinical oncology, 12(12), 1994, pp. 2654-2666
Authors:
MERTENS WC
EISENHAUER EA
MOORE M
VENNER P
STEWART D
MULDAL A
WONG D
Citation: Wc. Mertens et al., GEMCITABINE IN ADVANCED RENAL-CELL CARCINOMA - A PHASE-II STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA-CLINICAL-TRIALS-GROUP, Annals of oncology, 4(4), 1993, pp. 331-332
Authors:
THIGPEN JT
BERTELSEN K
EISENHAUER EA
HACKER NF
LUND B
SESSA C
Citation: Jt. Thigpen et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH ADVANCED OVARIAN-CARCINOMA TREATED WITH CHEMOTHERAPY, Annals of oncology, 4, 1993, pp. 35-40